Latest News & Features
Refine Search
Americas
Healthcare investment yields the best returns when focusing on its core aims and forging strong partnerships, James Flynn, managing partner of Deerfield, tells LSIPR. 16 July 2018
Biotechnology
As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal. 13 July 2018
Americas
McDermott Will & Emery has strengthened its IP team with the addition of a former DLA Piper partner. 13 July 2018
Americas
A former employee pleaded guilty to stealing trade secrets from what is now the world’s largest chemicals company earlier this week. 13 July 2018
Americas
BMS’s teams are working to answer key questions and more intimately understand the interplay between the immune system and cancer, Paul Golian, vice president and assistant counsel of IP at BMS, tells LSIPR. 13 July 2018
Americas
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets. 12 July 2018
Biotechnology
Europol has seized 360 tonnes of counterfeit or illegal pesticides across Europe over the course of 20 days, in what the agency has deemed its largest-ever haul of fake pesticides. 12 July 2018
Americas
Scott Alban of AstraZeneca outlines the company’s recent transformation aimed at breaking down barriers and the uncharted territories that it is eager to explore. 12 July 2018
Genetics
The world of sequence variation IP is complicated and confusing, and fraught with legal risk, but there is a solution, as Ellen Sherin of GQ Life Sciences reports. 12 July 2018
Big Pharma
The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU. 11 July 2018